Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm
Joint Authors
Mauricio, Dídac
Lucas Martín, Anna M.
Guanyabens, Elena
Zavala-Arauco, R.
Chamorro, Joaquín
Granada, Maria Luisa
Puig-Domingo, Manuel
Source
International Journal of Endocrinology
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-05-18
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Type 2 diabetes (T2D) exists in 25–40% of hospitalized patients.
Therapeutic inertia is the delay in the intensification of a treatment and it is frequent in T2D.
The objectives of this study were to detect patients admitted to surgical wards with hyperglycaemia (HH; fasting glycaemia > 140 mg/dL) as well as those with T2D and suboptimal chronic glycaemic control (SCGC) and to assess the midterm impact of treatment modifications indicated at discharge.
A total of 412 HH patients were detected in a period of 18 months; 86.6% (357) had a diagnosed T2D.
Their preadmittance HbA 1c was 7.7 ± 1.5%; 47% (189) had HbA 1c ≥ 7.4% (SCGC) and were moved to the upper step in the therapeutic algorithm at discharge.
Another 15 subjects (3.6% of the cohort) had T2D according to their current HbA 1c .
Ninety-four of the 189 SCGC patients were evaluated 3–6 months later.
Their HbA 1c before in-hospital-intervention was 8.6 ± 1.2% and 7.5 ± 1.2% at follow-up ( P < 0.004 ).
Active detection of hyperglycaemia in patients admitted in conventional surgical beds permits the identification of T2D patients with SCGC as well as previously unknown cases.
A shift to the upper step in the therapeutic algorithm at discharge improves this control.
Hospitalization is an opportunity to break therapeutic inertia.
American Psychological Association (APA)
Lucas Martín, Anna M.& Guanyabens, Elena& Zavala-Arauco, R.& Chamorro, Joaquín& Granada, Maria Luisa& Mauricio, Dídac…[et al.]. 2015. Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm. International Journal of Endocrinology،Vol. 2015, no. 2015, pp.1-5.
https://search.emarefa.net/detail/BIM-1065674
Modern Language Association (MLA)
Lucas Martín, Anna M.…[et al.]. Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm. International Journal of Endocrinology No. 2015 (2015), pp.1-5.
https://search.emarefa.net/detail/BIM-1065674
American Medical Association (AMA)
Lucas Martín, Anna M.& Guanyabens, Elena& Zavala-Arauco, R.& Chamorro, Joaquín& Granada, Maria Luisa& Mauricio, Dídac…[et al.]. Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm. International Journal of Endocrinology. 2015. Vol. 2015, no. 2015, pp.1-5.
https://search.emarefa.net/detail/BIM-1065674
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1065674